The global in-vitro diagnostics instruments market was valued at US$ 7,316.9 Mn in 2016 and is estimated to reach US$ 13,881.5 Mn in 2026 at a CAGR of 6.6% from 2017 to 2026. The immunochemistry segment in the global In-vitro diagnostics instruments market is estimated to account for major revenue share of 25.3% in 2017. By product type: Immunochemistry segment is estimated to register a CAGR of over 7.7. By end user: Hospitals and diagnostic laboratories segment is estimated to account for highest revenue share among the application segments, registering a CAGR of over 7.3% over the forecast period. By region: The market in North America accounted for highest revenue share in 2016, and is expected to record CAGR of over 6.6% between 2016 and 2026.
↧